Compounds in development to combat hyperphosphataemia (Q34481935)

2 August 2017

1 reference

title

Compounds in development to combat hyperphosphataemia (English)

1 reference

2 August 2017

Ritz E

1

1 reference

2 August 2017

Hergesell O

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

published in

1 reference

2 August 2017

volume

10

1 reference

2 August 2017

issue

12

1 reference

2 August 2017

page(s)

2185-2190

1 reference

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

Value of electron-beam computed tomography for the noninvasive detection of high-grade coronary-artery stenoses and occlusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

Cardiac and arterial interactions in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

Why are dialysis patients malnourished?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

Neurodevelopmental effects of lanthanum in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

Treatment of hyperlipidaemia in patients on chronic haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

CALCIUM AND PHOSPHORUS METABOLISM IN OSTEOMALACIA. XI. THE PATHOGENETIC ROLE OF PREGNANCY AND RELATIVE IMPORTANCE OF CALCIUM AND VITAMIN D SUPPLY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

The development and in-vitro evaluation of novel mixed metal hydroxy-carbonate compounds as phosphate binders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

Oral phosphate binders: phosphate binding capacity of iron (III) hydroxide complexes containing saccharides and their effect on the urinary excretion of calcium and phosphate in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2185

10.1517/13543784.10.12.2185

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference